Protein Engineering Market Size, Share, and Trends 2024 to 2034

The global protein engineering market size accounted for USD 4.35 billion in 2024, grew to USD 5.09 billion in 2025, and is expected to be worth around USD 20.86 billion by 2034, poised to grow at a CAGR of 16.97% between 2024 and 2034. The North America protein engineering market size is predicted to increase from USD 1.78 billion in 2024 and is estimated to grow at the fastest CAGR of 17.11% during the forecast year.

  • Last Updated : November 2024
  • Report Code : 2767
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Protein Engineering Market 

5.1. COVID-19 Landscape: Protein Engineering Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Protein Engineering Market, By Product

8.1. Protein Engineering Market, by Product, 2024-2034

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Software & Services

8.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Protein Engineering Market, By Technology

9.1. Protein Engineering Market, by Technology, 2024-2034

9.1.1. Rational Protein Design

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Directed Evolution

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Hybrid Approach

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. De Novo Protein Design

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Protein Engineering Market, By Protein Type 

10.1. Protein Engineering Market, by Protein Type, 2024-2034

10.1.1. Others

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Monoclonal Antibodies

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Vaccines

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Colony Stimulating Factor

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Coagulation Factors

10.1.5.1. Market Revenue and Forecast (2021-2034)

10.1.6. Other Proteins

10.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Protein Engineering Market, By End-User

11.1. Protein Engineering Market, by April, 2024-2034

11.1.1. Academic Research Institutes

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Contract Research Organizations

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Pharmaceutical & Biotechnology Companies

11.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Protein Engineering Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.2. Market Revenue and Forecast, by Technology (2021-2034)

12.1.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.1.4. Market Revenue and Forecast, by End-User(2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.1.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.1.5.4. Market Revenue and Forecast, by End-User(2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.6.2. Market Revenue and Forecast, by Technology (2021-2034)

12.1.6.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.1.6.4. Market Revenue and Forecast, by End-User(2021-2034)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.2. Market Revenue and Forecast, by Technology (2021-2034)

12.2.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.2.4. Market Revenue and Forecast, by End-User(2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.2.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.2.5.4. Market Revenue and Forecast, by End-User(2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)

12.2.6.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.2.6.4. Market Revenue and Forecast, by End-User(2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)

12.2.7.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.2.7.4. Market Revenue and Forecast, by End-User(2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.8.2. Market Revenue and Forecast, by Technology (2021-2034)

12.2.8.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.2.8.4. Market Revenue and Forecast, by End-User(2021-2034)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.2. Market Revenue and Forecast, by Technology (2021-2034)

12.3.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.3.4. Market Revenue and Forecast, by End-User(2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.3.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.3.5.4. Market Revenue and Forecast, by End-User(2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)

12.3.6.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.3.6.4. Market Revenue and Forecast, by End-User(2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)

12.3.7.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.3.7.4. Market Revenue and Forecast, by End-User(2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.8.2. Market Revenue and Forecast, by Technology (2021-2034)

12.3.8.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.3.8.4. Market Revenue and Forecast, by End-User(2021-2034)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.2. Market Revenue and Forecast, by Technology (2021-2034)

12.4.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.4.4. Market Revenue and Forecast, by End-User(2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.4.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.4.5.4. Market Revenue and Forecast, by End-User(2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)

12.4.6.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.4.6.4. Market Revenue and Forecast, by End-User(2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)

12.4.7.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.4.7.4. Market Revenue and Forecast, by End-User(2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.8.2. Market Revenue and Forecast, by Technology (2021-2034)

12.4.8.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.4.8.4. Market Revenue and Forecast, by End-User(2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.5.4. Market Revenue and Forecast, by End-User(2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.5.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.5.5.4. Market Revenue and Forecast, by End-User(2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.6.2. Market Revenue and Forecast, by Technology (2021-2034)

12.5.6.3. Market Revenue and Forecast, by Protein Type (2021-2034)

12.5.6.4. Market Revenue and Forecast, by End-User(2021-2034)

Chapter 13. Company Profiles

13.1. Amgen, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Agilent Technologies

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Bruker Cor.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Thermo Fisher Scientific, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. PerkinElmer, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Waters Corp.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Bio-Rad Laboratories

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Merck KGaA

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Danaher Corp.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. GenScript Biotech Corp.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client